Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in March - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported quarterly
adjusted
earnings of 11 cents​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of 37 cents per share.
    * Revenue fell 5.6% to $55.59 million from a year ago;
analysts
expected $57.40 million. 
    * The mean earnings estimate of analysts had risen by
about 63% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Mesa Laboratories Inc shares had fallen by 17.6% this
quarter and lost 13.4% so far this year.
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $205.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
25 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.37           0.11           Missed
 Dec. 31 2022      0.14           0.08           Missed
 Sep. 30 2022      -0.31          0.24           Beat
 Jun. 30 2022      1.00           -0.27          Missed

Recent news on Mesa Laboratories

See all news